BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19374981)

  • 41. Gamma-butyrolactone autoregulators and receptor proteins in non- Streptomyces actinomycetes producing commercially important secondary metabolites.
    Choi SU; Lee CK; Hwang YI; Kinosita H; Nihira T
    Arch Microbiol; 2003 Oct; 180(4):303-7. PubMed ID: 14523609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploitation of phage battery in the search for bioactive actinomycetes.
    Kurtböke DI
    Appl Microbiol Biotechnol; 2011 Feb; 89(4):931-7. PubMed ID: 21120467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polyhydroxyalkanoates production by actinobacteria isolated from soil.
    Matias F; Bonatto D; Padilla G; Rodrigues MF; Henriques JA
    Can J Microbiol; 2009 Jul; 55(7):790-800. PubMed ID: 19767851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical screening: a simple approach to visualizing Streptomyces diversity for drug discovery and further research.
    Taddei A; Valderrama M; Giarrizzo J; Rey M; Castelli C
    Res Microbiol; 2006 Apr; 157(3):291-7. PubMed ID: 16176869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
    Subramani R; Aalbersberg W
    Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New antibiotics from bacterial natural products.
    Clardy J; Fischbach MA; Walsh CT
    Nat Biotechnol; 2006 Dec; 24(12):1541-50. PubMed ID: 17160060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biosynthesis pathways for deoxysugars in antibiotic-producing actinomycetes: isolation, characterization and generation of novel glycosylated derivatives.
    Salas JA; Méndez C
    J Mol Microbiol Biotechnol; 2005; 9(2):77-85. PubMed ID: 16319497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
    Rebets Y; Brötz E; Tokovenko B; Luzhetskyy A
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):387-402. PubMed ID: 24127068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes.
    Onaka H
    J Antibiot (Tokyo); 2017 Jul; 70(8):865-870. PubMed ID: 28442735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elicitation of secondary metabolism in actinomycetes.
    Abdelmohsen UR; Grkovic T; Balasubramanian S; Kamel MS; Quinn RJ; Hentschel U
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):798-811. PubMed ID: 26087412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marine actinomycetes as a source of novel secondary metabolites.
    Fiedler HP; Bruntner C; Bull AT; Ward AC; Goodfellow M; Potterat O; Puder C; Mihm G
    Antonie Van Leeuwenhoek; 2005 Jan; 87(1):37-42. PubMed ID: 15726289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity-Independent Discovery of Secondary Metabolites Using Chemical Elicitation and Cheminformatic Inference.
    Pimentel-Elardo SM; Sørensen D; Ho L; Ziko M; Bueler SA; Lu S; Tao J; Moser A; Lee R; Agard D; Fairn G; Rubinstein JL; Shoichet BK; Nodwell JR
    ACS Chem Biol; 2015 Nov; 10(11):2616-23. PubMed ID: 26352211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chapter 18. Molecular genetic approaches to analyze glycopeptide biosynthesis.
    Wohlleben W; Stegmann E; Süssmuth RD
    Methods Enzymol; 2009; 458():459-86. PubMed ID: 19374994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism.
    Hoskisson PA; Seipke RF
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
    Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myxobacteria isolated in Israel as potential source of new anti-infectives.
    Gaspari F; Paitan Y; Mainini M; Losi D; Ron EZ; Marinelli F
    J Appl Microbiol; 2005; 98(2):429-39. PubMed ID: 15659197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmaceutically active secondary metabolites of marine actinobacteria.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism.
    Craney A; Ozimok C; Pimentel-Elardo SM; Capretta A; Nodwell JR
    Chem Biol; 2012 Aug; 19(8):1020-7. PubMed ID: 22921069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbial technologies for the discovery of novel bioactive metabolites.
    Donadio S; Monciardini P; Alduina R; Mazza P; Chiocchini C; Cavaletti L; Sosio M; Puglia AM
    J Biotechnol; 2002 Nov; 99(3):187-98. PubMed ID: 12385708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.
    Huang C; Leung RK; Guo M; Tuo L; Guo L; Yew WW; Lou I; Lee SMY; Sun C
    Sci Rep; 2016 Feb; 6():20667. PubMed ID: 26864220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.